Felix Pharmaceuticals goal is to provide companion pets with high-quality, reasonably priced bio-equivalent generics.
Felix Pharmaceuticals has raised $175.0M in total funding. The most recent round was Private Equity. The last funding was announced in June 2025.
Felix Pharmaceuticals's investors include Advent International.
Felix Pharmaceuticals is headquartered in Dublin, Ireland.
Felix Pharmaceuticals goal is to provide companion pets with high-quality, reasonably priced bio-equivalent generics.
Felix Pharmaceuticals is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Felix Pharmaceuticals — Funding & Investors." VCBacked, June 9, 2025, https://www.vcbacked.co/company/felix-pharmaceuticals. Accessed November 16, 2026.
VCBacked. (2025). Felix Pharmaceuticals — Funding & Investors. Retrieved November 16, 2026, from https://www.vcbacked.co/company/felix-pharmaceuticals
{{cite web |title=Felix Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/felix-pharmaceuticals |website=VCBacked |access-date=November 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Felix Pharmaceuticals? Request a listing update